Related Experiment Video
Updated: May 7, 2026
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Tunable cytotoxicity of rhodamine 6G via anion variations
Paul K S Magut1, Susmita Das, Vivian E Fernand
1Department of Chemistry, Louisiana State University , Baton Rouge, Louisiana 70803, United States.
Abstract:
Chemotherapeutic agents with low toxicity to normal tissues are a major goal in cancer research. In this regard, the therapeutic activities of cationic dyes, such as rhodamine 6G, toward cancer cells have been studied for decades with observed toxicities toward normal and cancer cells. Herein, we report rhodamine 6G-based organic salts with varying counteranions that are stable under physiological conditions, display excellent fluorescence photostability, and more importantly have tunable chemotherapeutic properties. Our in vitro studies indicate that the hydrophobic compounds of this series allow production of nanoparticles which are nontoxic to normal cells and toxic to cancer cells. Furthermore, the anions, in combination with cations such as sodium, were observed to be nontoxic to both normal and cancer cells. To the best of our knowledge, this is the first demonstration that both the cation and anion play an extremely important and cooperative role in the antitumor properties of these compounds.
Insights
New rhodamine 6G-based organic salts offer tunable chemotherapy with reduced toxicity. Both the cation and anion components cooperatively enhance antitumor properties, showing promise for safer cancer treatment.
Area of Science:
- Materials Science
- Nanotechnology
- Cancer Research
Background:
- Developing chemotherapeutic agents with low normal tissue toxicity is crucial in cancer research.
- Cationic dyes like rhodamine 6G have shown therapeutic potential against cancer cells but often exhibit toxicity to both normal and cancerous cells.
- Understanding the mechanisms of dye-based chemotherapy is essential for improving treatment efficacy and safety.
Purpose of the Study:
- To synthesize and characterize novel rhodamine 6G-based organic salts with tunable chemotherapeutic properties.
- To investigate the toxicity profiles of these novel compounds and their derived nanoparticles toward normal and cancer cells.
- To explore the cooperative role of both cation and anion components in the observed antitumor activities.
Main Methods:
- Synthesis of rhodamine 6G-based organic salts with various counteranions.
- Evaluation of compound stability under physiological conditions.
- Assessment of fluorescence photostability.
- In vitro cytotoxicity assays on normal and cancer cell lines.
- Nanoparticle formulation and characterization.
- In vitro evaluation of nanoparticle toxicity and efficacy.
Main Results:
- Rhodamine 6G-based organic salts were synthesized, exhibiting stability and excellent fluorescence photostability.
- Hydrophobic compounds formed nanoparticles that were non-toxic to normal cells but toxic to cancer cells.
- Specific anion combinations with cations, such as sodium, demonstrated no toxicity to either normal or cancer cells.
- The study highlights a cooperative role between the cation and anion in determining the antitumor properties.
Conclusions:
- Novel rhodamine 6G-based organic salts possess tunable chemotherapeutic properties with potential for targeted cancer therapy.
- The developed nanoparticles show selective toxicity towards cancer cells, sparing normal cells.
- This research is the first to demonstrate the significant and cooperative contribution of both cation and anion to the antitumor efficacy of these compounds.
